Please login to the form below

treatment access

This page shows the latest treatment access news and features for those working in and with pharma, biotech and healthcare.

Pfizer's Ibrance scores second-line breast cancer approval via NICE’s Cancer Drugs Fund

We know how important it is for women to have access to treatment options that can delay the progression of their disease and help them live a normal life for longer, ... However, it then re-considered its decision after Pfizer submitted an ‘improved

Latest news

Personalised medicine can improve treatment, but access still an issue

Barriers to access could harm uptake of potentially transformative therapies. Personalised medicines such as gene therapies may improve identification of optimal treatment but gaining access to these treatments still poses an ... For the NHS, access to
NICE turns down Roche’s Tecentriq for triple-negative breast cancer

negative breast cancer (TNBC), an aggressive form of the disease with few treatment options. ... diagnosed with TNBC in England would be eligible for treatment with the regimen if an access deal can be agreed.
NICE delivers final ‘no’ for Novartis’ migraine treatment Aimovig

did not specify how many previous treatment they had failed before taking the drug. ... Clearly this is not the result we’ve been working towards; with chronic migraine patients in England who could benefit from Aimovig being denied routine access to
Roche’s Hemlibra scores broader NHS funding

The market access agreement in England has been achieved once again via direct pricing and access negotiations with budget holder NHS England, with NICE not involved at all. ... This decision will mean that people will have the opportunity to have
NICE’s fast-track catapults Skyrizi into market

new psoriasis treatment gain market access in record time. ... Dr Alice Butler, UK medical director, AbbVie confirmed last month that Skyrizi’s NICE fast-track appraisal would make it the fastest ever market access approval for any psoriasis biologic

More from news
Approximately 1 fully matching, plus 209 partially matching documents found.

Latest Intelligence

As the opioid crisis grabs the headlines, the search for safe treatments continues

science. Access to healthcare in heightened risk groups where people have low self-esteem and do not seek treatment, combined with stigmatising methods of controlled supervision and reduced funding for support ... They reach about 50% of those people who
Rare diseases: redefining medical communications

Low levels of clinical awareness and expertise, small patient populations, paucity of data, and access to treatment are all factors that drive the need for new approaches, compared with those used ... Access to treatment. The demonstration of value is
The Cystic Fibrosis Buyers’ Club

Diarmaid McDonald is lead organiser of Just Treatment, a UK-based patient activist group which is challenging the government to take whatever steps necessary to ensure access to new medicines at ... Diarmaid McDonald, lead organiser, Just Treatment. The
25 Women Leaders in UK Healthcare

with a rare condition for which there is no diagnosis, or no treatment, or where there is no access to new therapies on the NHS. ... greater access to diagnosis and treatment.
Gene therapy market access Q&A

Jesper Jorgensen, Health Economics and Market Access Manager, Cell and Gene Therapy Catapult. ... Getting this right is extremely important as a marketing authorisation is of little use to anyone if patients can’t access the treatment.

More from intelligence
Approximately 1 fully matching, plus 46 partially matching documents found.

Latest appointments

UN names special envoy for HIV/ AIDS in Africa

Ugandan national Wandira-Kazibwe replaces Asha-Rose Migiro as the UN's lead advocate to end HIV-related stigma, improve access to treatment and improve national public health systems.
Basilea's Hans Christian Rohde takes up commercial role at uniQure

access to this crucial treatment to as many patients as possible.

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

How do companies prepare for reimbursement?

For example, mixed treatment analysis will help to understand current clinical unmet need. ... These elements are clear markers of discrepancies between commercial and market access strategies.
Early diagnosis underpins NHS cancer strategy

Raising greater awareness of the symptoms of cancer, lowering the threshold for referral by GPs, accelerating access to diagnosis and treatment and maximising the number of cancers identified through screening will ... RDCs comprise multi-disciplinary
OPEN Health reflections on the World Orphan Drug Congress in Barcelona

therapies and associated referral and treatment pathways; and then building communications plans which are clear, demonstrate the value and reach the right audiences is critical. ... treatment. Although there is still some way to go, we are
Tapping the potential of rare diseases: A journey into uncharted territory

Low levels of clinical awareness and expertise, small patient populations, paucity of data, and access to treatment are all factors that drive the need for new approaches, compared with those used ... Access to treatment. The demonstration of value is
The 2019 WHO essential medicine list: Narrowing the access gap to innovative cancer treatments

Velcade. Millennium. Treatment of patients with. newly diagnosed multiple myeloma in both non-transplant and transplant eligible/available settings. . ... The inclusion of innovative medicines in the WHO EML is an important step to help patients gain

More from PMHub
Approximately 0 fully matching, plus 24 partially matching documents found.

Featured jobs

Account Manager– Medical Communications: (Negotiable - depending on experience)

Consultant: competitive salary

Senior Medical Writer, MedComms Agency: Salary TBC

Principal Medical Writer: £48 - 58, 000 according to skills and experience benefits

Vice President: Competitive Salary Offered

Account Director or Senior Account Director: Salary TBC

Account Director, Medical Communications & Events: £50 - 65, 000 according to skills and experience benefits

Director of Scientific Services, Medical Communications, Six fig...: Six figure salary

Subscribe to our email news alerts

PMHub

Add my company

Havas Lynx Group

We are the Havas Lynx Group. Devoted to fresh thinking. Changing the way the world does healthcare communications for the...

Latest intelligence

How do companies prepare for reimbursement?: Valid Insight explore how to optimise your market access strategy during new product development, how to address payer concerns and prepare for reimbursement....
Integrating electronic health records into clinical trials: How organisations are working to realise the research potential of EHRs...
Keeping up the fight against HIV and using the lessons to tackle other threats: Danny Buckland interviews Gilead’s Mike Elliott...